Skip to main content
OpenTrials
Completed

NCT Number: NCT07583758

Clinical Trial on the Methodology of Hysterosalpingography: a Comparative Study

Different techniques have been developed to optimize hysterosalpingography (HSG) methodology. Our aim is to compare the advantages and disadvantages of these three different techniques in terms of both patient satisfaction and clinician's interpretation. The medical records of the patients who are treated in our hospital between 2020 and 2022 are investigated based on the eligibility criteria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Hysterosalpingography Urogenital Diseases

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul Medipol University, Medipol Mega University Hospital

Istanbul, 34214, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patients with infertility

Exclusion criteria

  • Male patients
  • Patients who are diagnosed with menopause
  • Patients who do not want to proceed with HSG for diagnosis purposes

Treatment and study plan

Hysterosalpingography - Metal Cannula Method

Diagnostic Test

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

Hysterosalpingography - Active Balloon Method

Diagnostic Test

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

Hysterosalpingography - Passive Balloon Method

Diagnostic Test

Different techniques of hysterosalpingography (HSG) were applied for 3 groups in parallel.

Primary outcomes

  1. Patient Satisfaction

    Time frame: Day 1

    Patients' visual analogue scores (VAS) immediately after the procedure and 30 minutes post-procedure are recorded, respectively. The pain is assessed by the principal investigator.

    The visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

  2. Clinician's Interpretation

    Time frame: Day 1

    The interpretation is classified as "clearly evaluated", "partially evaluated" and as "could not be evaluated" by the clinician.

Sponsors and collaborators

Lead sponsor

Medipol University

Other

Collaborators

  • Istanbul Medipol University Hospital

Registry information

Acronym: MethodHSG

Important dates

Study start
2020
Primary completion
2022
Study completion
2026
First posted
May 13, 2026
Registry last updated
May 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.